Oral absorption of voriconazole is affected by SLCO2B1 c.396T>C genetic polymorphism in CYP2C19 poor metabolizers - Lee, Sang Won; Oh, Jaeseong; Kim, Andrew HyoungJin; Ji, Sang Chun; Park, Sang-In; Yoon, Seo Hyun; Chung, Jae-Young; Yu, Kyung-Sang; Jang, In-Jin; Lee, SeungHwan (The pharmacogenomics journal, 2020)
Keywords: 45/77; 631/208/212/1728; 692/308/53/2423; Antifungal agents; Biomarkers; Biomedical and Life Sciences; Biomedicine; Drug dosages; Enzymatic activity; Enzymes; Fungal infections; Gene Expression; Gene polymorphism; Hospitals; Human Genetics; Intestine; Medicine; Metabolism; Oncology; Organic anion transporting polypeptide; Pharmacokinetics; Pharmacology; Pharmacotherapy; Phenotypes; Plasma; Polymorphism; Psychopharmacology; Quality control; Voriconazole